TTPH stock is the stock symbol for Tetraphase Pharmaceuticals, Inc., a biopharmaceutical company that specializes in the development and commercialization of novel antibiotics for the treatment of serious bacterial infections. The company was founded in 2006 and is headquartered in Watertown, Massachusetts.
Tetraphase Pharmaceuticals, Inc.'s lead product candidate is eravacycline, a novel intravenous antibiotic for the treatment of complicated intra-abdominal infections and complicated urinary tract infections. The company has also developed a pipeline of other antibiotics targeting multidrug-resistant bacteria.
As of March 7, 2023, the market capitalization of Tetraphase Pharmaceuticals, Inc. was approximately $55.9 million USD. It is important to note that investing in biopharmaceutical companies can be risky due to the nature of drug development and regulatory approval processes.
TTPH stock is the stock symbol for Tetraphase Pharmaceuticals, Inc., a biopharmaceutical company that specializes in the development and commercialization of novel antibiotics for the treatment of serious bacterial infections. The company was founded in 2006 and is headquartered in Watertown, Massachusetts.